Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
McKinsey
AstraZeneca
Merck
Baxter

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

REMICADE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for REMICADE

Identify potential brand extensions & biosimilar entrants

SponsorPhase
M.D. Anderson Cancer CenterEarly Phase 1
National Cancer Institute (NCI)Early Phase 1
University of LiverpoolPhase 2

See all REMICADE clinical trials

Recent Litigation for REMICADE

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC.2019-12-31
CELGENE CORPORATION v. HETERO LABS LIMITED2019-07-16
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12

See all REMICADE litigation

PTAB Litigation
PetitionerDate
Dr. Reddy's Laboratories, Inc.2018-08-03

See all REMICADE litigation

Pharmacology for REMICADE

Patent Text Search: US Patents for REMICADE

These patents were identified by searching patent claims

Supplementary Protection Certificates for REMICADE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122010000047 Germany   Start Trial PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE: EU/1/10/618/001-004 20100526
233 5006-2015 Slovakia   Start Trial PRODUCT NAME: IBRUTINIB; REGISTRATION NO/DATE: EU/1/14/945 20141023
CR 2015 00021 Denmark   Start Trial PRODUCT NAME: IBRUTINIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 20141023
C20170010 00279 Estonia   Start Trial PRODUCT NAME: IBRUTINIIB;REG NO/DATE: EU/1/14/945 07.07.2015
C 2009 001 Romania   Start Trial PRODUCT NAME: ABATACEPT PROTEINADE FUZIUNE 1-25-ONCOSTATIN M(PRECURSOR UMAN) CU PROTEINA DE FUZIUNE AANTIGENULUI UMAN CTLA-4 CU FRAGMENTUL GREUAL CATENEI DE IMUNOGLOBULINA G1 UMANA - ABATACEPT; NATIONAL AUTHORISATION NUMBER: RO EU/1/07/389/001, RO EU/1/07/389/002, RO EU/1/07/389/003; DATE OF NATIONAL AUTHORISATION: 20070521; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/07/389/001, EMEA EU/1/07/389/002, EMEA EU/1/07/389/003; DATE OF FIRST AUTHORISATION IN EEA: 20070521
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Boehringer Ingelheim
Colorcon
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.